Randomized Controlled Trial

Citations 61-70 of 86 total displayed.

Past content (since Nov 1998):

Original Contributions
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Craig W. Ritchie; Ashley I. Bush; Andrew Mackinnon; Steve Macfarlane; Maree Mastwyk; Lachlan MacGregor; Lyn Kiers; Robert Cherny; Qiao-Xin Li; Amanda Tammer; Darryl Carrington; Christine Mavros; Irene Volitakis; Michel Xilinas; David Ames; Stephen Davis; Konrad Beyreuther; Rudolph E. Tanzi; Colin L. Masters
Arch Neurol 2003; 60: 1685-1691. [Abstract] [Full text] [PDF]  

Original Contributions
A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease

The Parkinson Study Group
Arch Neurol 2003; 60: 1721-1728. [Abstract] [Full text] [PDF]  

Original Contributions
A Phase 1 Trial of Riluzole in Spinal Muscular Atrophy

Barry S. Russman; Susan T. Iannaccone; Frederick J. Samaha
Arch Neurol 2003; 60: 1601-1603. [Abstract] [Full text] [PDF]  

Original Contributions
Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy

Susan T. Iannaccone; Linda S. Hynan
Arch Neurol 2003; 60: 1130-1136. [Abstract] [Full text] [PDF]  

Original Contributions
A Randomized Trial of Amantadine in Huntington Disease

Padraig O'Suilleabhain; Richard B. Dewey Jr
Arch Neurol 2003; 60: 996-998. [Abstract] [Full text] [PDF]  

Original Contributions
Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial

Martin Farlow; Steven Potkin; Barbara Koumaras; Jeffrey Veach; Dario Mirski
Arch Neurol 2003; 60: 843-848. [Abstract] [Full text] [PDF]  

Controversies in Neurology
Should the Multicenter Carotid Endarterectomy Trials Be Repeated?

Seemant Chaturvedi
Arch Neurol 2003; 60: 774-775. [Extract] [Full text] [PDF]  

Controversies in Neurology
Resolved: NASCET and ACAS Need Not Be Repeated: The Affirmative Position

Wesley S. Moore
Arch Neurol 2003; 60: 775-778. [Extract] [Full text] [PDF]  

Controversies in Neurology
How Should We Design Studies for Stroke Prevention?

Steven T. DeKosky
Arch Neurol 2003; 60: 778-779. [Extract] [Full text] [PDF]  

Original Contributions
A Controlled Trial of Rasagiline in Early Parkinson Disease: The TEMPO Study

Parkinson Study Group
Arch Neurol 2002; 59: 1937-1943. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9